Eliem Therapeutics, Inc.

Targets: 1
Filings: 1
Median premium: 15%
First filing: May 17, 2024
Latest filing: May 17, 2024

Targets

Company	Takeover score	Filings	Latest
CLYMClimb Bio, Inc.	3	1	May 17, 2024

Deal filings

Filed	Company	Form	Price	Premium
May 17, 2024	CLYMClimb Bio, Inc.	PREM14A	$3.84	15.4%